Skip to content
Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article Looking Ahead to a Psychedelic 2023

Looking Ahead to a Psychedelic 2023

  • Post published:February 27, 2023
  • Post category:2022 Year in Review
Read more about the article COMPASS Pathways plc to announce fourth quarter and year-end 2022 financial results on 28 February 2023

COMPASS Pathways plc to announce fourth quarter and year-end 2022 financial results on 28 February 2023

  • Post published:February 24, 2023
  • Post category:Press Release
Read more about the article Opinions | Do Mice Hallucinate? Do Humans Head-Twitch?

Opinions | Do Mice Hallucinate? Do Humans Head-Twitch?

  • Post published:February 24, 2023
  • Post category:Opinions
Read more about the article Numinus to Participate in a Water Tower Research Fireside Chat on Tuesday, February 28, 2023

Numinus to Participate in a Water Tower Research Fireside Chat on Tuesday, February 28, 2023

  • Post published:February 24, 2023
  • Post category:Press Release
Read more about the article MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

  • Post published:February 24, 2023
  • Post category:Press Release
Read more about the article Transcend Therapeutics announces Series A funding round of $40 million

Transcend Therapeutics announces Series A funding round of $40 million

  • Post published:February 23, 2023
  • Post category:Press Release
Read more about the article The Psychedelic Educators Network

The Psychedelic Educators Network

  • Post published:February 23, 2023
  • Post category:2022 Year in Review
Read more about the article Panel: Psychedelic Careers

Panel: Psychedelic Careers

  • Post published:February 23, 2023
  • Post category:2022 Year in Review
Read more about the article MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

  • Post published:February 22, 2023
  • Post category:Press Release
Read more about the article Israel-Based Clearmind Medicine Files Patent Applications for Three Unique Combinations of Future Psychedelic-Based Compounds

Israel-Based Clearmind Medicine Files Patent Applications for Three Unique Combinations of Future Psychedelic-Based Compounds

  • Post published:February 22, 2023
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More